Paper35580686
IgG functionalized polymeric nanoparticles for oral insulin administration.
De Marchi JGB and 8 others. Int J Pharm, 2022. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. IgG functionalized polymeric nanoparticles for oral insulin administration. Papers, record 35580686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35580686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin | Major topic |
| Nanoparticles | Major topic |
| Administration, Oral | |
| Drug Carriers | |
| Immunoglobulin G | |
| Pharmaceutical Preparations | |
| Polymers |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42646208 | Development of an Electro-Responsive Sorafenib-Loaded Polypyrrole Coating-Modified Nickel-Titanium Alloy for Tumor Ablation Therapy. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42646208 | PubMed |
| 41599783 | Emerging Breakthroughs in Nano-Ginseng Innovations and Their Therapeutic Implications in Type 2 Diabetes. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41599783 | PubMed |
| 41585434 | Strategies for overcoming multiple barriers of oral administration of protein and peptide therapeutics. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41585434 | PubMed |
| 41103493 | Exploring the potential of polymers: advancements in oral nanocarrier technology. | Beilstein J Nanotechnol | 2025 | https://conductscience.org/library/papers/41103493 | PubMed |
| 40488852 | Synthesis, characterization, and drug delivery application of carboxymethyl chitosan-CTAB self-assembling. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40488852 | PubMed |
| 37376294 | Insulin-Loaded Soybean Trypsin Inhibitor-Chitosan Nanoparticles: Preparation, Characterization, and Protective Effect Evaluation. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/37376294 | PubMed |
| 36976228 | Chitosan/Albumin Coating Factorial Optimization of Alginate/Dextran Sulfate Cores for Oral Delivery of Insulin. | Mar Drugs | 2023 | https://conductscience.org/library/papers/36976228 | PubMed |
| 36068795 | Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy. | Diabetes Metab Syndr Obes | 2022 | https://conductscience.org/library/papers/36068795 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35580686
GET https://conductscience.org/api/papers/v1/35580686/authors